L.P. Ra Capital Management Sells Shares of HOWL
On June 15, 2026, L.P. Ra Capital Management sold 128,770 shares of HOWL.
Key Points
- L.P. Ra Capital Management sold 128,770 shares of HOWL on June 15, 2026, at $0.39 per share, valued at $50,220.3.
- HOWL shares traded at $0.36 with notable insider selling activity by RA Capital Management.
- Analysts like HC Wainwright & Co. maintain a 'buy' rating with a $4.00 target, as peers adjust their holdings.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
L.P. Ra Capital Management recently sold 128,770 shares of HOWL on June 15, 2026. The shares were sold at an average price of $0.39, bringing the total transaction value to approximately $50,220.3. This transaction was not part of a pre-planned trading program.
Insider Buying and Selling at Werewolf Therapeutics, Inc.
RA Capital Management has been actively trading shares of HOWL. On June 15, 2026, the firm sold 128,770 shares at $0.39 each. This follows a series of sales, including 149,625 shares on June 16 at $0.37 and 170,441 shares on June 12 at $0.40. Earlier in the month, they sold 262,503 shares on June 11 at $0.38 and 369,800 shares on June 9 at $0.37.
Other Institutional Activity in HOWL
RA Capital Management, L.P. holds a significant position in HOWL with 6,681,307 shares valued at $5,562,856, unchanged recently. Vanguard Capital Management LLC added 1,217,976 shares, now holding the same amount worth about $1,014,574. MPM BioImpact LLC reduced its stake by 184,747 shares, leaving it with 1,208,810 shares valued at approximately $1,006,455. Meanwhile, Lynx1 Capital Management LP increased its holdings slightly by 1,860 shares, totaling 657,786 shares valued at $547,673.
Analysts Set New Price Targets
Analysts remain optimistic about HOWL's prospects. On December 19, 2025, HC Wainwright & Co. maintained a 'buy' rating with a price target of $4.00. B of A Securities also maintained a 'buy' rating with targets of $7.00 and $8.00 in previous updates. JMP Securities has consistently maintained a 'buy' rating, with a target of $3.00 set on August 21, 2025. Wedbush reiterated a 'buy' rating with a target of $8.00 earlier in the year.
Bottom Line
L.P. Ra Capital Management's recent sale of HOWL shares is part of ongoing insider activity, reflecting dynamic trading behavior. Investors often watch such transactions closely for insights, though they don't necessarily predict future stock performance. Analysts continue to support HOWL with 'buy' ratings, suggesting confidence in its potential despite recent insider sales.
Get Werewolf Therapeutics, Inc. alerts
New 13F filings, insider trades, and analyst moves on $HOWL, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.